Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation …

JA Marin-Neto, A Rassi Jr, CA Morillo, A Avezum… - American heart …, 2008 - Elsevier
BACKGROUND: Benznidazole is effective for treating acute and chronic (recently acquired)
Trypanosoma cruzi infection (Chagas' disease). Recent data indicate that parasite …
被引用次数：255 相关文章

[引用][C] Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole …

JA MARIN-NETO, A RASSI… - The American heart …, 2008 - pascal-francis.inist.fr
Rationale and design of a randomized placebo-controlled trial assessing the effects of
etiologic treatment in Chagas' cardiomyopathy : The BENznidazole Evaluation For …

[引用][C] Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in chagas' cardiomyopathy: the BENznidazole …

JA Marin-Neto - American Heart Journal, 2008 - repositorio.usp.br
ReP USP - Detalhe do registro: Rationale and design of a randomized placebo-controlled
trial assessing the effects of etiologic treatment in chagas' cardiomyopathy: the …

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation …

JA Marin-Neto, A Rassi Jr, CA Morillo… - American Heart …, 2008 - europepmc.org
Background Benznidazole is effective for treating acute and chronic (recently acquired)
Trypanosoma cruzi infection (Chagas' disease). Recent data indicate that parasite …
[PDF] academia.edu

[PDF][PDF] Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole …

FA de Cardiología, S Argentina, SP Preto… - American Heart …, 2008 - academia.edu
Study Design BENEFIT is a multicenter, randomized, double-blind, placebo-controlled
clinical trial of 3,000 patients with Chagas' cardiomyopathy in Latin America. Patients are …
[PDF] psu.edu

[PDF][PDF] Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole …

FA de Cardiología, S Argentina, SP Preto… - American Heart …, 2008 - Citeseer
Study Design BENEFIT is a multicenter, randomized, double-blind, placebo-controlled
clinical trial of 3,000 patients with Chagas' cardiomyopathy in Latin America. Patients are …

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation …

JA Marin-Neto, A Rassi Jr, CA Morillo, A Avezum… - 2008 - pubmed.ncbi.nlm.nih.gov
Background Benznidazole is effective for treating acute and chronic (recently acquired)
Trypanosoma cruzi infection (Chagas' disease). Recent data indicate that parasite …

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation …

JA Marin Neto, A Rassi Júnior, CA Morillo, A Avezum… - 2008 - cabidigitallibrary.org
Background: Benznidazole is effective for treating acute and chronic (recently acquired)
Trypanosoma cruzi infection (Chagas' disease). Recent data indicate that parasite …

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation …

JA Marin-Neto, A Rassi, CA Morillo, A Avezum… - American Heart …, 2008 - infona.pl
Benznidazole is effective for treating acute and chronic (recently acquired) Trypanosoma
cruzi infection (Chagas' disease). Recent data indicate that parasite persistence plays a …

[引用][C] Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole …

JA MARIN-NETO, A RASSI, CA MORILLO… - The American heart …, 2008 - Mosby